PPTHSPelthos Therapeutics Inc.

Pelthos Therapeutics Inc.

PTHS

$19.81-3.39%

End of day · as of Oct 13, 2026, 2:00 AM ET

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive PTHS chart

  • Mkt cap

    $94.75M

  • EV/Sales

    N/A

  • P/E ratio

    N/A

  • FY2025 Revenue

    $16.80M

  • EPS (TTM)

    $-28.55

  • Gross Margin (FY2025)

    76.25%

  • Profit Margin (FY2025)

    -257.93%

  • Beta

    N/A

  • Div yield

    N/A

  • Sector

    Healthcare

No recent filings in cache.

Live PTHS terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

PTHS — Pelthos Therapeutics Inc. · rev $16.8M

PTHS Key Statistics

  • Market Cap: $94.7M
  • P/B Ratio: 2.67
  • Previous Close: $20.50
  • Volume: 56,281
  • Day Range: $19.81 – $20.36

Pelthos Therapeutics Inc. latest statements (FY2025)

Latest cached year on this hub. Full PTHS income, balance, and cash tables.

  • Revenue$16.8M
  • Net Income-$43.3M

PTHS FAQ

What industry is PTHS in?

Pelthos Therapeutics Inc. (PTHS) is a biotechnology company in the Healthcare sector.

What are PTHS's latest revenue and net income?

Latest cached Pelthos Therapeutics Inc. (PTHS) revenue for Dec 31, 2025 was $16.8M. Net income was -$43.3M. Statements: https://lician.com/financials/pths

What is PTHS's market cap?

Pelthos Therapeutics Inc. (PTHS) market capitalization is $94.7M on the latest cached snapshot.

What are PTHS's previous close, day range, and volume?

Pelthos Therapeutics Inc. (PTHS) cached previous close $20.50; day range $19.81 – $20.36; volume 56,281. Session quote: https://lician.com/quote/pths

Live PTHS terminal loads when you scroll near this section.